Ohad Hammer Overview

  • Primary Position
  • Partner & Board...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 8

  • Med. Deal Size

  • Med. Valuation

Ohad Hammer General Information

Biography

Mr. Ohad Hammer serves as Board Member at Adcytherix. He also serves as a Partner at Pontifax Venture Capital. He served as Board Member at Pi Therapeutics. He serves as Board Member at Adcendo and Precirix. He served as a Member of the Supervisory Board at Emergence Therapeutics. He is a Board Member of Keros Therapeutics and AgomAb Therapeutics. He joined Pontifax in 2009 and is involved in identifying as well as evaluating new investment opportunities. He focuses on early-stage projects and oversees scouting, due diligence and company formation. He also supports development and business development activities within our early-stage portfolio companies. He obtained his M.S. in Biology from Tel-Aviv University. He was a Board Member at TargEDys. He serves as Board of director at Explore Bio. He serves as Board Member at Step Pharma.

Contact Information

Primary Position
Partner & Board Member, Pontifax Venture Capital
Education
Tel Aviv University, MS (Master of Science)
Tel Aviv University, BS (Bachelor of Science)
Gender
Male
Phone
+972
Address
  • 14 Shenkar Street
  • Herzliya 46725
  • Israel
+972

Ohad Hammer Positions (1)

Firm name Firm type Title Location Industry Since
Pontifax Venture Capital Investor Partner & Board Member Herzliya, Israel Venture Capital

Ohad Hammer Board Seats (8)

Company Industry Ownership Status Financing Status Location Since
Adcendo Drug Discovery Privately Held (backing) Venture Capital-Backed Frederiksberg, Denmark
Adcytherix Drug Discovery Privately Held (backing) Venture Capital-Backed Marseille, France
AgomAb Drug Discovery Privately Held (backing) Venture Capital-Backed Antwerp, Belgium
Keros Therapeutics Biotechnology Publicly Held Formerly VC-backed Lexington, MA
Pontifax Venture Capital Herzliya, Israel

Ohad Hammer Lead Partner on Deals (20)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Adcendo 04-Apr-2023 Later Stage VC (Series A) Completed Drug Discovery Frederiksberg, Denmark
AgomAb 13-Jul-2022 Completed Drug Discovery Antwerp, Belgium
Precirix 16-Mar-2022 Completed Biotechnology Brussels, Belgium
Emergence Therapeutics 07-Dec-2021 Completed Drug Discovery Duisburg, Germany
PulseSight Therapeutics 04-Aug-2021 Completed Drug Discovery Paris, France
Step Pharma 24-Mar-2021 Completed Drug Discovery Saint-Genis-Pouilly, France
Keros Therapeutics 04-Mar-2020 Completed Biotechnology Lexington, MA
Metabomed 19-Dec-2019 Completed Drug Discovery Yavne, Israel
AgomAb 10-Oct-2019 Early Stage VC (Series A) Completed Drug Discovery Antwerp, Belgium
Pi Therapeutics 29-May-2019 Early Stage VC (Series B) Completed Drug Discovery Ness Ziona, Israel

Ohad Hammer Network (220)

Board Members (117)

Name Company Representing Location From
Francesco Sinigaglia Ph.D PulseSight Therapeutics PulseSight Therapeutics Paris, France
Ximing Ding Ph.D Adcytherix Pureos Bioventures Marseille, France
Precirix Precirix Brussels, Belgium
Dynacure Self France
Step Pharma Inserm Transfert Saint-Genis-Pouilly, France

Portfolio Executives (97)

Name Company Role Deal date Location
Carmel Lynch Ph.D Adcendo Chief Development Officer 04-Apr-2023 Frederiksberg, Denmark
Henrik Stage Adcendo Co-Founder 04-Apr-2023 Frederiksberg, Denmark
Adcendo Chief Technology Officer 04-Apr-2023 Frederiksberg, Denmark
Adcendo VP Operations, General Manager & Co-founder 04-Apr-2023 Frederiksberg, Denmark
Adcendo ESG & Finance Director 04-Apr-2023 Frederiksberg, Denmark

Fund Team Members (6)

Name Investor Fund Fund Location
Silvia Noiman Ph.D Pontifax Venture Capital Pontifax Fund IV Herzliya, Israel
Silvia Noiman Ph.D Pontifax Venture Capital Pontifax Fund III Herzliya, Israel
Pontifax Venture Capital Herzliya, Israel
Pontifax Venture Capital Herzliya, Israel
Pontifax Venture Capital Herzliya, Israel

Ohad Hammer Affiliated Funds (3)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Pontifax Fund III Pontifax Venture Capital Venture - General Closed 2011
Pontifax Fund IV Pontifax Venture Capital Venture - General Closed 2015
Pontifax Fund VI Pontifax Venture Capital Venture - General Closed 2020

Ohad Hammer FAQs

  • Who is Ohad Hammer?

    Mr. Ohad Hammer serves as Board Member at Adcytherix.

  • How much does Ohad Hammer typically invest?

    Ohad Hammer's median deal size is .

  • What is Ohad Hammer’s main position?

    Ohad Hammer’s primary position is Partner & Board Member.

  • How many active board seats does Ohad Hammer hold?

    Ohad Hammer holds 8 board seats including Adcendo, Adcytherix, AgomAb, Keros Therapeutics, and Pontifax Venture Capital.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »